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1. Introduction 
Adenosine and adenosine deaminase appear to 
play a crucial role in lymphocyte maturation. 5'-Nu- 
cleotidase, an ecto-enzyme which produces adenosine 
from extracellular 5'-AMP [1 ], displays very low activ- 
ity in immature lymphocytes [2-5]. In the human, 
adenosine can induce lymphocyte maturation [6]. 
However, high levels of adenosine deaminase (ADA), 
which leads to inosine, were found in immature 
lymphocytes [7]. It was postulated that adenosine 
deaminase is involved in lymphocyte maturation [8]. 
ADA deficiency leads to severe combined immuno- 
deficiency, characterized bythe lack of mature T and 
B lymphocytes [9]. 
Very low 5'-nucleotidase (5'N)activities were 
reported in thymocytes from various pecies [ 10-14]. 
We have shown that in mouse this low level was due to 
the high percentage of peanut agglutinin (PNA)-posi- 
tive, hydrocortisone-sensitive thymocytes, which 
almost lack 5'N activity [14]; this population isthought 
to represent immature cortical cells; on the contrary, 
PNA-negative thymocytes, which are immunocom- 
petent, hydrocortisone-resistant and could represent 
the medullary population, display a 10-fold higher 
5'N level [14]. This result is conflicting with [15] 
where no difference between 5'N activities in rat 
medullary and cortical thymocytes was found. 
T Human lymphoblastoid cell lines of acute lym- 
phocytic leukemia (ALL) origin lack also 5'N activity 
[16]. These cells display very high terminal deoxynu- 
cleotidyl transferase (TdT) activity and were described 
as immature [17]. 
In [ 18] 5'N activity of unseparated human thymo- 
cytes increased after incubation of these cells with 
factors known to induce thymocyte maturation. This 
result prompted us to verify if immature human thymo- 
cytes lack 5'N activity, like immature mouse thymo- 
cytes [14], and if 5'N levels can be used as a marker 
of human cell maturation as postulated in [2-5]. We 
also measured ADA activities of human mature and 
immature thymocytes. 
Human lymphoblastoid cell lines are often used as 
models of lymphoid cell subpopulations, as they pos- 
sess some of the characteristics of normal cells. We 
determined 5'N and ADA activities in some of these 
cell lines displaying mature or immature properties. 
2. Materials and methods 
Normal peripheral blood lymphocytes were purified 
from heparinized blood by centrifugation f Ficoll- 
Hypaque [19]. Tonsil lymphocytes were purified as 
in [20]. Normal human thymuses were obtained from 
children undergoing cardiac surgery; thymuses were 
minced in PBS (pH 7.4) then passed through a t'me 
stainless teel mesh to give a single cell suspension. 
When necessary erythrocytes were selectively killed 
by 0.14 M ammonium chloride. Cell viability was 
always >92%. 
Mature and immature thymocyte populations were 
isolated by agglutination with PNA as in [21]. Thymo- 
cytes, 108 in 0.25 ml PBS, were incubated with 0.5 mg 
PNA in 0.25 ml PBS for 15 min at 25°C; the mixture 
was then layered on 8 ml 50% fetal calf serum (FCS) 
in PBS. After 30 min sedimentation at 1 × g, aggluti- 
nated (immature) cells (bottom layer) were removed 
from non-agglutinated (mature) cells (top layer), dis- 
sociated into single cells by 10 min incubation at 
37°C with 5 ml 0.2 M D-galactose in PBS, washed 
twice with 5 ml 0.2 M D-galactose and twice with 
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PBS. Unagglutinated cells (5-10% of total thymocytes) 
received the same treatment. 
The malignant T lymphoblastoid cell lines MOLT-3, 
MOLT-4, JM, H-SB2, the B cell line CCRF-SB, and 
the non-T non-B leukemia cell lines REH and K 562 
were provided by Clin-Midy Research Center 
(Montpellier). 4 B lymphoblastoid cell lines were 
established by Dr Malissen (Institut d'Immunologie, 
Marseille Luminy) after infection of normal circulating 
lymphocytes with Epstein-Barr virus. Cells maintained 
in RPMI 1640, 10% FCS, were collected when they 
reached 106 cells/ml. 
5'-Nucleotidase activity was determined using 
5'- [ a2 p] AMP as substrate [ 16]. Measures were per- 
formed as in [22] with intact cells, the specificity of 
5'-AMP hydrolysis was assessed by several controls: 
specific inhibition by anti-5'N [23] and concanavalin 
A [24], lack of inhibition by the substrates of non- 
specific phosphatases [ 1 ]. 
Adenosine deaminase was measured using [all]- 
adenosine as substrate, on lymphocytes permeabilized 
with Lubrol PX, as in [16]. 
5'N activity was expressed as nmol Pi" h-l" mg 
protein-I, ADA activity as nmol inosine, min -x .mg 
protein -1. The amount of proteins corresponding to
the cells was determined by Lowry's method. 
3. Results and discussion 
3.1.5'N and ADA activities of human lymphocytes 
Like for mouse thymocytes [25] the major popu- 
lation of human thymocytes (80-90% of cells) binds 
PNA and can be separated from thymocytes which do 
not bind the lectin. As reported in [21] the PNA* sub- 
population did not respond to PHA, while the minor 
subpopulation (10-15% of total cells) did exhibit 
this response xactly like blood circulating lympho- 
cytes (PBL): our results (not shown) were identical to 
those in [21] where the immature character of PNA ÷ 
cells and the mature character of PNA- cells was 
shown. 
5'N activities of both populations are reported in 
table 1 ; for 3 different experiments he 5'N activity 
of PNA- thymocytes i  5-fold higher than that of 
PNA* thymocytes. We have shown [14] that PNA or 
D-galactose did not inhibit 5'N activity. The low 5'N 
activity of PNA ÷ thymocytes i  not related to an 
inhibition process but to the lack of 5'N active sites, 
as evidenced by the fact that 5'N of unseparated cells 
reflects the percentage ofPNA- and PNA ÷ populations. 
The high 5'N level of mature PNA- thymocytes i  
similar to that of tonsil lymphocytes and slightly 
lower than that of peripheral blood lymphocytes 
Table 1 
5'N and ADA activities of human lymphocytes 
Cells 5'N ADA 5'N 
(nmol. h -1 . mg -1 ) (nmol. min -~ . mg -~) 
ADA 
Thymocytes: 
Exp. 1 unseparated 64 n.d. a 
PNA* 45 470 0.095 
PNA- 204 200 1 
Exp.2 unseparated 65 n.d 
PNA ÷ 40 490 0.08 
PNA- 280 200 1.4 
Exp. 3 unseparated 72 n.d 
PNA ÷ 60 450 0.13 
PNA- 300 210 1.5 
PBL: 274 -+ 82 70 - 17 3.9 
Tonsil ymphocytes: 246 -+ 30 100 -+ 20 2.5 
a Not determined 
5'N and ADA activities of unseparated, PNA ÷ and PNA- thymocytes were measured in
3 different expt as in section 2. Each measure was carried out in triplicate and the preci- 
sion is >5%. 5'N and ADA activities of peripheral b ood lymphocytes (PBL) and tonsil 
lymphocytes were measured infive different experiments; he mean value of the activity 
and the standard eviation are reported 
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(table 1). We did not measure the 5'N activity of T 
and B PBL separated by the rosetting technique 
because the 2 populations are submitted to very dif- 
ferent treatments (hemolysis, different number of 
centrifugations), which might differently affect their 
membrane nzymatic activities and especially their 
5'N activity which can easily be detached from the 
plasma membranes [16]; it could explain the opposite 
results reported for circulating T and B cells [26,27]. 
We also reported ADA activities of mature and 
immature thymocytes (table 1): PNA ÷ cells display 
2-2.5-fold higher ADA activity than PNA- cells; the 
same result was observed for mouse thymocytes [16]. 
It is consistent with the data in [7] where immature 
rat thymocytes, eparated by density gradient centrif- 
ugation, displayed ADA activity 2-3-fold higher than 
that of mature thymocytes. The ADA activity of 
human PNA- thymocytes was found 2-fold higher 
than that of unseparated PBL and of tonsil lympho- 
cytes. 
The ratio 5'N/ADA is >10-fold higher in PNA- 
than in PNA ÷ thymocytes. This ratio is even greater in 
PBL or tonsil lymphocytes: 2-times with respect o 
PNA- thymocytes and >20-times with respect o 
PNA ÷ thymocytes. 
3.2.5'Nand ADA activities of human lymphoblastoid 
cell lines 
Several authors found undetectable 5'N levels in 
various lymphoblastoid cell lines [28-31 ], using 
5'-AMP radiolabelled on the adonosine moiety as sub- 
strate [28,32]; in [16] such substrates were shown 
unsuitable for the determination of 5'N activity on 
intact cells. We measured 5'N activities of several 
human lymphoblastoid cell lines using 5'-[ 32p] AMP 
as substrate [16]: we found very low but detectable 
5'N levels in T-ALL cell lines, with the exception of 
MOLT-3 and H-SB2 cells which almost completely 
lack the activity (table 2). EBV-induced B lympho- 
blasts displayed higher 5'N activity, close to that of 
normal PBL. H-SB2 and CCRF-SB lymphoblasts further 
proved this point: these 2 cell lines are issued from 
the same patient [33]; H-SB2 are T-ALL cells and 
lack completely 5'N activity while CCRF-SB of mature 
B origin have relatively high 5'N level (110 nmol .  
h-1. mg protein-I). At the same time ADA activity 
was high in T-ALL cells and low in B lymphoblasts. 
The non-T non-B (null) leukemia line REH showed 
also low 5'N and high ADA levels. Another null cell 
line K562 [17] had low ADA and almost normal 5'N 
activities; however, this cell line, of chronic myeloid 
leukemia origin is properly considered an erythro- 
myeloid cell line rather than a lymphoblast [34]. A 
low TdT level for K562 cells and high TdT level for 
REH cells was reported in [ 17]. 
B-ALL lymphoblasts behave like T-ALL cells - low 
5'N and high ADA activities [35]. On the contrary 
EBV-induced lymphoblasts have 5'N and ADA levels 
similar to those of normal human PBL. 
Table 2 
5'N and ADA activities of human lymphoblastoid cell lines 
Cell lines Origin TdT 5'N ADA 
level a (nmol. h -~ . mg -~) (nmol. min -~ . mg -a) 
5'N 
ADA 
MOLT-3 T-ALL b H 0 803 ± 200 
MOLT-4 T-ALL H 11 ± 4 740 ± 100 
JM T-ALL H 35 ± 12 240 +- 50 
H-SB2 T-ALL H 0 360 ± 30 
REH NullC-ALL H 41 ± 6 210 ± 20 
K562 NulI-CML d L 73 ± 18 39 ± 10 
CCRF-SB B ceU e L 110 ± 32 35 ± 12 
EBV-B lympho- 
blasts [4] Normal PBL L 165 ± 36 62 ± 13 
0 
0.01 
0.15 
0 
0.40 
1.88 
3.10 
2.64 
a TdT levels as reported by [17]: low (L) or h~.lg, d(H) 
b Acute lymphocytic leukemia; c Non-T non-B; Chronic myeloblastic leukemia 
e Apparently normal B cell deriving from the same ALL patient who gave H-SB2 cell lines [33] 
The mean values and standard eviations are reported (3 expt) 
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4. Conclusion 
These data show that different levels of 5'N and 
ADA are associated with different stages of human 
lymphocyte maturation. Like for mouse lymphocytes 
[16] we found an inverse relationship between 5'N 
and ADA activities, with low 5'N and high ADA values 
in PNA ÷ thymocytes, high 5'N and low ADA values in 
PNA- thymocytes, tonsil ymphocytes and PBL. 
The result concerning 5'N is not consistent with 
that in [15] where similar 5'N values were reported in 
mature and immature rat thymocytes, but it agrees 
with our data on mouse thymocytes [14] and with 
the demonstration f an increase of 5'N activity during 
in vitro human thymocyte maturation [18]. 
We also found very low 5'N and high ADA activities 
in several lymphoblastoid ceil lines from acute lympho- 
cytic leukemia (T or null) (table 2 and [ 16]). A similar 
result was reported for a B-ALL patient [34]. Very 
low 5'N/ADA ratios characterize allkinds of ALL 
lymphoblasts and not their T, B or null character. 
These ceils are known to possess immature character- 
istics such as high TdT activity [17]. 
Two different cell lines (REH and K562) described 
as non-T non-B leukemia lines [17] display very dif- 
ferent 5'N/ADA ratios. REH cells of ALL origin have 
low 5'N/ADA ratio (table 2) and high TDT activity 
[17], KR62 (chronic myeloblastic leukemia [34]) 
show high 5'N/ADA ratio and low TdT activity [17]. 
B lymphoblastoid cell lines deriving from normal 
mature B lymphocytes transformed by Epstein-Barr 
virus display low TdT activity, like mature cells [17]. 
We found in 4 such lines high 5'N and low ADA levels. 
It is often postulated that the differences of 5'N and 
ADA activities between T and B lymphoblastoid ceil 
lines are related to their T or B character. But this 
hypothesis not supported by the low 5'N activity 
of B lymphoid ceils arrested in an early stage of 
maturation [5 ] and by the data on B-ALLlymphocytes 
[35] and on T and B normal ymphocytes [27]; B and 
T cord blood lymphocytes are also claimed to have 
low similar 5'N activity [3]. 
A good correlation appears between high TdT 
activity and low 5'N/ADA ratio and vice-versa. If we 
consider that TdT is one of the features of immature 
cells, it might be the same for the 5'N/ADA ratio. 
Lymphocytes from peripheral blood and tonsils which 
include a majority of immunocompetent cells show 
high 5'N/ADA ratios unlike PNA ÷ (immature) thymo- 
cytes. However, further investigations should be nee- 
essary to confirm the relationship between 5'N/ADA 
ratio and the stage of cell maturation. 
The physiological meaning of the increase of this 
ratio during cell maturation is poorly understood. 
5'N is a glycoprotein and one of the high affinity 
receptor of concanavalin A [24]; it is inhibited by the 
binding of this lectin mitogen. It appears involved in 
the uptake of adenosine from extracellular nucleo- 
tides [36] and in the regulation of cyclic AMP levels 
[37] through adenosine receptors. In [38] we showed 
the presence of such receptors on immature thymo- 
cytes, which is consistent with the possible involve- 
ment of cyclic AMP in adenosine-induced thymocyte 
maturation [6]. 
The high ADAlevel of immature lymphocytes might 
be an adaptation mechanism because of the low avail- 
ability of adenosine in cells with low 5'N levels. The 
fact that ADA deficiency prevents cell maturation and 
leads to immunodeficiency emphasizes the importance 
of adenosine metabolism in lymphocyte maturation 
and function. 
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